Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 45

1.

Safety and efficacy of low molecular weight heparin therapy during pregnancy: three year experience at a tertiary care center.

Singh N, Varshney P, Tripathi R, Mala YM, Tyagi S.

J Obstet Gynaecol India. 2013 Dec;63(6):373-7. doi: 10.1007/s13224-013-0412-4. Epub 2013 Jun 12.

PMID:
24431682
[PubMed]
2.

Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism.

Hokusai-VTE Investigators, Büller HR, Décousus H, Grosso MA, Mercuri M, Middeldorp S, Prins MH, Raskob GE, Schellong SM, Schwocho L, Segers A, Shi M, Verhamme P, Wells P.

N Engl J Med. 2013 Oct 10;369(15):1406-15. doi: 10.1056/NEJMoa1306638. Epub 2013 Aug 31. Erratum in: N Engl J Med. 2014 Jan 23;370(4):390.

PMID:
23991658
[PubMed - indexed for MEDLINE]
Free Article
3.

NOACs for thromboprophylaxis in medical patients.

Cohen AA, Rider T.

Best Pract Res Clin Haematol. 2013 Jun;26(2):183-90. doi: 10.1016/j.beha.2013.07.002. Epub 2013 Jul 21. Review.

PMID:
23953906
[PubMed - indexed for MEDLINE]
4.

[Economic analysis of dalteparin use in knee surgery at Instituto Mexicano del Seguro Social].

Arreola-Ornelas H, Rosado-Buzzo A, García-Mollinedo L, Dorantes Aguilar J, Muciño-Ortega E, Mould-Quevedo JF.

Cir Cir. 2012 Sep-Oct;80(5):411-8. Spanish.

PMID:
23351443
[PubMed - indexed for MEDLINE]
5.

[Budgetary impact for the National Health System of apixaban prophylaxis of venous thromboembolism in patients undergoing total knee or hip replacement].

Gómez Arrayas I, Suárez Fernández C, Gómez Cerezo JF, Betegón Nicolás L, de Salas-Cansado M, Rubio-Terrés C.

Rev Esp Salud Publica. 2012 Dec;86(6):601-12. doi: 10.4321/S1135-57272012000600006. Spanish.

PMID:
23325135
[PubMed - indexed for MEDLINE]
Free Article
6.

Comparison of antithrombotic and haemorrhagic effects of edoxaban, an oral direct factor Xa inhibitor, with warfarin and enoxaparin in rats.

Morishima Y, Honda Y, Kamisato C, Tsuji N, Kita A, Edo N, Shibano T.

Thromb Res. 2012 Sep;130(3):514-9. doi: 10.1016/j.thromres.2012.05.008. Epub 2012 May 29.

PMID:
22647432
[PubMed - indexed for MEDLINE]
7.

Apixaban: a new player in the anticoagulant class.

Agrawal R, Jain P, Dikshit SN.

Curr Drug Targets. 2012 Jun;13(6):863-75. Review.

PMID:
22250655
[PubMed - indexed for MEDLINE]
8.

The role of apixaban for venous and arterial thromboembolic disease.

Prom R, Spinler SA.

Ann Pharmacother. 2011 Oct;45(10):1262-83. doi: 10.1345/aph.1Q119. Epub 2011 Sep 27. Review.

PMID:
21954450
[PubMed - indexed for MEDLINE]
9.

Oral rivaroxaban for symptomatic venous thromboembolism.

EINSTEIN Investigators, Bauersachs R, Berkowitz SD, Brenner B, Buller HR, Decousus H, Gallus AS, Lensing AW, Misselwitz F, Prins MH, Raskob GE, Segers A, Verhamme P, Wells P, Agnelli G, Bounameaux H, Cohen A, Davidson BL, Piovella F, Schellong S.

N Engl J Med. 2010 Dec 23;363(26):2499-510. doi: 10.1056/NEJMoa1007903. Epub 2010 Dec 3.

PMID:
21128814
[PubMed - indexed for MEDLINE]
Free Article
10.

Invited commentary.

Henke PK.

J Vasc Surg. 2010 Nov;52(5):1270-1. doi: 10.1016/j.jvs.2010.06.069. No abstract available.

PMID:
21050988
[PubMed - indexed for MEDLINE]
Free Article
11.

Inhibition of the intrinsic coagulation pathway factor XI by antisense oligonucleotides: a novel antithrombotic strategy with lowered bleeding risk.

Zhang H, Löwenberg EC, Crosby JR, MacLeod AR, Zhao C, Gao D, Black C, Revenko AS, Meijers JC, Stroes ES, Levi M, Monia BP.

Blood. 2010 Nov 25;116(22):4684-92. doi: 10.1182/blood-2010-04-277798. Epub 2010 Aug 31.

PMID:
20807891
[PubMed - indexed for MEDLINE]
Free Article
12.

Long-term efficacy and safety of once-daily enoxaparin plus warfarin for the outpatient ambulatory treatment of lower-limb deep vein thrombosis in the TROMBOTEK trial.

Kurtoglu M, Koksoy C, Hasan E, Akcalı Y, Karabay O, Filizcan U; TROMBOTEK Study Group.

J Vasc Surg. 2010 Nov;52(5):1262-70. doi: 10.1016/j.jvs.2010.06.070. Epub 2010 Aug 21.

PMID:
20732787
[PubMed - indexed for MEDLINE]
Free Article
13.

New options with dabigatran etexilate in anticoagulant therapy.

Maegdefessel L, Spin JM, Azuma J, Tsao PS.

Vasc Health Risk Manag. 2010 May 25;6:339-49. Review.

PMID:
20531953
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Frequency of bleeding following invasive dental procedures in patients on low-molecular-weight heparin therapy.

Hong CH, Napeñas JJ, Brennan MT, Furney SL, Lockhart PB.

J Oral Maxillofac Surg. 2010 May;68(5):975-9. doi: 10.1016/j.joms.2009.09.054. Epub 2010 Feb 9.

PMID:
20144498
[PubMed - indexed for MEDLINE]
15.

Anticoagulation for cerebral venous thrombosis with subarachnoid hemorrhage: a case report.

Hegazi MO, Ahmed S, Sakr MG, Hassanien OA.

Med Princ Pract. 2010;19(1):73-5. doi: 10.1159/000252839. Epub 2009 Dec 9.

PMID:
19996624
[PubMed - indexed for MEDLINE]
16.

Life-threatening retroperitoneal bleeding due to warfarin-drug interactions.

Chan TY.

Pharmacoepidemiol Drug Saf. 2009 May;18(5):420-2. doi: 10.1002/pds.1729.

PMID:
19283775
[PubMed - indexed for MEDLINE]
17.

Comparison of different dose regimens of enoxaparin in deep vein thrombosis therapy in pregnancy.

Narin C, Reyhanoglu H, Tülek B, Onoglu R, Ege E, Sarigül A, Yeniterzi M, Durmaz I.

Adv Ther. 2008 Jun;25(6):585-94. doi: 10.1007/s12325-008-0068-0.

PMID:
18568442
[PubMed - indexed for MEDLINE]
18.

Post discharge prophylactic anticoagulation in gastric bypass patient-how safe?

Ojo P, Asiyanbola B, Valin E, Reinhold R.

Obes Surg. 2008 Jul;18(7):791-6. doi: 10.1007/s11695-007-9382-x. Epub 2008 Apr 3.

PMID:
18386108
[PubMed - indexed for MEDLINE]
19.

Thromboprophylaxis and peripheral nerve blocks in patients undergoing joint arthroplasty.

Chelly JE, Schilling D.

J Arthroplasty. 2008 Apr;23(3):350-4. doi: 10.1016/j.arth.2007.05.045.

PMID:
18358371
[PubMed - indexed for MEDLINE]
20.

Central retinal vein occlusion secondary to protein S deficiency.

Yap YC, Barampouti F.

Ann Ophthalmol (Skokie). 2007 Winter;39(4):343-4.

PMID:
18025659
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk